{"id":"spirapril-hydrochloride","rwe":[{"pmid":"21726637","year":"2011","title":"Perfusion calorimetry in the characterization of solvates forming isomorphic desolvates.","finding":"","journal":"European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences","studyType":"Clinical Study"},{"pmid":"12872612","year":"2003","title":"Drug interaction of spirapril hydrochloride monohydrate and hydrochlorothiazide. A clinical study to compare the pharmacokinetics after administration of spirapril hydrochloride monohydrate tablets, hydrochlorothiazide tablets and fixed combination bi-layer tablets.","finding":"","journal":"Arzneimittel-Forschung","studyType":"Clinical Study"},{"pmid":"11325479","year":"2001","title":"Chemical reactivity in solid-state pharmaceuticals: formulation implications.","finding":"","journal":"Advanced drug delivery reviews","studyType":"Clinical Study"},{"pmid":"9572901","year":"1998","title":"Formation of isomorphic desolvates: creating a molecular vacuum.","finding":"","journal":"Journal of pharmaceutical sciences","studyType":"Clinical Study"}],"tags":[{"label":"spirapril","category":"class"},{"label":"Small Molecule","category":"modality"},{"label":"Angiotensin-converting enzyme","category":"target"},{"label":"ACE","category":"gene"},{"label":"C09AA11","category":"atc"},{"label":"Off-Patent","category":"patent"},{"label":"Active","category":"status"},{"label":"Hypertensive disorder","category":"indication"},{"label":"Approved 1990s","category":"decade"},{"label":"Angiotensin-Converting Enzyme Inhibitors","category":"pharmacology"},{"label":"Antihypertensive Agents","category":"pharmacology"},{"label":"Cardiovascular Agents","category":"pharmacology"},{"label":"Enzyme Inhibitors","category":"pharmacology"},{"label":"Protease Inhibitors","category":"pharmacology"}],"phase":"marketed","safety":{},"trials":[],"aliases":[],"patents":[],"pricing":[],"_sources":{"trials":{"url":"https://clinicaltrials.gov/search?intr=SPIRAPRIL HYDROCHLORIDE","method":"api_direct","source":"ClinicalTrials.gov","rawText":"","confidence":1,"sourceType":"ctgov","retrievedAt":"2026-04-20T01:14:31.217553+00:00"},"regulatory.ca":{"url":"","method":"api_direct","source":"Health Canada DPD","rawText":"","confidence":1,"sourceType":"health_canada_dpd","retrievedAt":"2026-04-20T01:14:37.861484+00:00"},"publicationCount":{"url":"https://pubmed.ncbi.nlm.nih.gov/?term=SPIRAPRIL HYDROCHLORIDE","method":"api_direct","source":"PubMed/NCBI","rawText":"","confidence":1,"sourceType":"pubmed","retrievedAt":"2026-04-20T01:14:38.239353+00:00"},"mechanism.target_chembl":{"url":"","method":"api_direct","source":"ChEMBL mechanism: Angiotensin-converting enzyme inhibitor","rawText":"","confidence":1,"sourceType":"chembl","retrievedAt":"2026-04-20T01:14:39.890365+00:00"},"crossReferences.chemblId":{"url":"https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL1200831/","method":"api_direct","source":"ChEMBL (EMBL-EBI)","rawText":"","confidence":1,"sourceType":"chembl","retrievedAt":"2026-04-20T01:14:39.544011+00:00"}},"allNames":"renormax","offLabel":[],"synonyms":["spirapril","spirapril hydrochloride","renormax","spirapril HCl"],"timeline":[{"date":"1994-12-29","type":"positive","source":"DrugCentral","milestone":"FDA approval"}],"aiSummary":"Renormax is a small molecule inhibitor of the angiotensin-converting enzyme, a type of enzyme involved in regulating blood pressure. It has been studied in clinical trials for various conditions, including post-stroke pneumonia, heart diseases, diabetes, and hypertension, often in combination with other treatments such as angiotensin converting enzyme inhibitors, Calcium Channel Blockers, and Angiotensin Receptor Blockers.","brandName":"Renormax","ecosystem":[{"indication":"Hypertensive disorder","otherDrugs":[{"name":"acebutolol","slug":"acebutolol","company":"Promius Pharma"},{"name":"aliskiren","slug":"aliskiren","company":"Novartis"},{"name":"amiloride","slug":"amiloride","company":"Paddock Llc"},{"name":"amlodipine","slug":"amlodipine","company":"Pfizer"}],"globalPrevalence":null}],"mechanism":{"target":"Angiotensin-converting enzyme","novelty":"Follow-on","targets":[{"gene":"ACE","source":"DrugCentral","target":"Angiotensin-converting enzyme","protein":"Angiotensin-converting enzyme"}],"modality":"Small Molecule","drugClass":"spirapril","explanation":"","oneSentence":"","technicalDetail":"Renormax inhibits the conversion of angiotensin I to angiotensin II, a potent vasoconstrictor, thereby reducing peripheral resistance and lowering blood pressure."},"commercial":{"launchDate":"1994","_launchSource":"DrugCentral (FDA 1994-12-29, )"},"references":[{"id":1,"url":"https://drugcentral.org/drugcard/2474","fields":["approvals","synonyms","ATC","PK","indications","contraindications","DDIs","targets","patents","FAERS"],"source":"DrugCentral"},{"id":2,"url":"https://clinicaltrials.gov/search?intr=SPIRAPRIL%20HYDROCHLORIDE","fields":["trials"],"source":"ClinicalTrials.gov"},{"id":3,"url":"https://pubmed.ncbi.nlm.nih.gov/?term=SPIRAPRIL HYDROCHLORIDE","fields":["publications"],"source":"PubMed/NCBI"},{"id":4,"url":"https://www.fda.gov/drugs/drug-approvals-and-databases/orange-book-data-files","fields":["patents","exclusivity","genericManufacturers"],"source":"FDA Orange Book"}],"_enrichedAt":"2026-03-30T02:39:36.216865","_validation":{"fieldsValidated":0,"lastValidatedAt":"2026-04-20T01:14:41.169902+00:00","fieldsConflicting":1,"overallConfidence":0.8},"biosimilars":[],"competitors":[{"drugName":"captopril","drugSlug":"captopril","fdaApproval":"1981-04-06","genericCount":21,"patentStatus":"Off-patent — generic available","relationship":"same-class"},{"drugName":"enalapril","drugSlug":"enalapril","fdaApproval":"1985-12-24","patentExpiry":"Nov 6, 2032","patentStatus":"Patent protected","relationship":"same-class"},{"drugName":"lisinopril","drugSlug":"lisinopril","fdaApproval":"1987-12-29","patentExpiry":"Nov 6, 2035","patentStatus":"Patent protected","relationship":"same-class"},{"drugName":"perindopril","drugSlug":"perindopril","fdaApproval":"1993-12-30","genericCount":5,"patentStatus":"Off-patent — generic available","relationship":"same-class"},{"drugName":"ramipril","drugSlug":"ramipril","fdaApproval":"1991-01-28","patentExpiry":"Aug 16, 2039","patentStatus":"Patent protected","relationship":"same-class"},{"drugName":"quinapril","drugSlug":"quinapril","fdaApproval":"1991-11-19","genericCount":12,"patentStatus":"Off-patent — generic available","relationship":"same-class"},{"drugName":"benazepril","drugSlug":"benazepril","fdaApproval":"1991-06-25","genericCount":12,"patentStatus":"Off-patent — generic available","relationship":"same-class"},{"drugName":"fosinopril","drugSlug":"fosinopril","fdaApproval":"1991-05-16","genericCount":10,"patentStatus":"Off-patent — generic available","relationship":"same-class"},{"drugName":"trandolapril","drugSlug":"trandolapril","fdaApproval":"1996-04-26","genericCount":10,"patentStatus":"Off-patent — generic available","relationship":"same-class"},{"drugName":"moexipril","drugSlug":"moexipril","fdaApproval":"1995-04-19","genericCount":4,"patentStatus":"Off-patent — generic available","relationship":"same-class"}],"genericName":"spirapril hydrochloride","indications":{"approved":[{"name":"Hypertensive disorder","source":"DrugCentral","snomedId":38341003,"regulator":"FDA"}],"offLabel":[],"pipeline":[]},"drugCategory":"active","labelChanges":[],"patentStatus":"Off-patent — no active Orange Book patents","relatedDrugs":[{"drugId":"captopril","brandName":"captopril","genericName":"captopril","approvalYear":"1981","relationship":"same-class"},{"drugId":"enalapril","brandName":"enalapril","genericName":"enalapril","approvalYear":"1985","relationship":"same-class"},{"drugId":"lisinopril","brandName":"lisinopril","genericName":"lisinopril","approvalYear":"1987","relationship":"same-class"},{"drugId":"perindopril","brandName":"perindopril","genericName":"perindopril","approvalYear":"1993","relationship":"same-class"},{"drugId":"ramipril","brandName":"ramipril","genericName":"ramipril","approvalYear":"1991","relationship":"same-class"},{"drugId":"quinapril","brandName":"quinapril","genericName":"quinapril","approvalYear":"1991","relationship":"same-class"},{"drugId":"benazepril","brandName":"benazepril","genericName":"benazepril","approvalYear":"1991","relationship":"same-class"},{"drugId":"fosinopril","brandName":"fosinopril","genericName":"fosinopril","approvalYear":"1991","relationship":"same-class"},{"drugId":"trandolapril","brandName":"trandolapril","genericName":"trandolapril","approvalYear":"1996","relationship":"same-class"},{"drugId":"moexipril","brandName":"moexipril","genericName":"moexipril","approvalYear":"1995","relationship":"same-class"}],"trialDetails":[{"nctId":"NCT07262710","phase":"","title":"Association of Angiotensin-Converting Enzyme Inhibitors and Angiotensin Receptor Blockers With Post-Stroke Pneumonia: A Real-World Retrospective Cohort Study","status":"NOT_YET_RECRUITING","sponsor":"First Teaching Hospital of Tianjin University of Traditional Chinese Medicine","startDate":"2025-12-01","conditions":["Post-stroke Pneumonia"],"enrollment":13656,"completionDate":"2026-08-19"},{"nctId":"NCT02817360","phase":"PHASE4","title":"NT-proBNP Selected Prevention of Cardiac Events in Diabetic Patients","status":"RECRUITING","sponsor":"Martin Huelsmann","startDate":"2016-02","conditions":["Heart Diseases","Diabetes Mellitus, Type 2"],"enrollment":2400,"completionDate":"2026-12"},{"nctId":"NCT00295542","phase":"PHASE4","title":"Ambulatory Blood Pressure Monitoring in the Prediction of Cardiovascular Events and Effects of Chronotherapy","status":"COMPLETED","sponsor":"University of Vigo","startDate":"2000-03","conditions":["Hypertension"],"enrollment":3344,"completionDate":"2009-04"}],"genericFilers":[],"latestUpdates":[],"manufacturing":[],"_patentsChecked":true,"crossReferences":{"NDDF":"006843","UNII":"96U2K78I3V","VANDF":"4020897","INN_ID":"6006","RXNORM":"36908","UMLSCUI":"C0075007","chemblId":"CHEMBL1200831","ChEMBL_ID":"CHEMBL431","KEGG_DRUG":"D03765","DRUGBANK_ID":"DB01348","PUBCHEM_CID":"5311447","SNOMEDCT_US":"713473008","IUPHAR_LIGAND_ID":"6575","SECONDARY_CAS_RN":"94841-17-5","MESH_SUPPLEMENTAL_RECORD_UI":"C052555"},"formularyStatus":[],"_enricherVersion":"v2","developmentCodes":[],"ownershipHistory":[],"pharmacokinetics":{"source":"DrugCentral","halfLife":"8.6 hours","clearance":"11.9 mL/min/kg","volumeOfDistribution":"0.43 L/kg"},"publicationCount":4,"therapeuticAreas":["Cardiovascular"],"atcClassification":{"source":"DrugCentral","atcCode":"C09AA11","allCodes":["C09AA11"]},"biosimilarFilings":[],"recentPublications":[{"date":"2011 Sep 18","pmid":"21726637","title":"Perfusion calorimetry in the characterization of solvates forming isomorphic desolvates.","journal":"European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences"},{"date":"2003","pmid":"12872612","title":"Drug interaction of spirapril hydrochloride monohydrate and hydrochlorothiazide. A clinical study to compare the pharmacokinetics after administration of spirapril hydrochloride monohydrate tablets, hydrochlorothiazide tablets and fixed combination bi-layer tablets.","journal":"Arzneimittel-Forschung"},{"date":"2001 May 16","pmid":"11325479","title":"Chemical reactivity in solid-state pharmaceuticals: formulation implications.","journal":"Advanced drug delivery reviews"},{"date":"1998 May","pmid":"9572901","title":"Formation of isomorphic desolvates: creating a molecular vacuum.","journal":"Journal of pharmaceutical sciences"}],"companionDiagnostics":[],"genericManufacturers":0,"_genericFilersChecked":true,"genericManufacturerList":[],"status":"approved","companyName":"","companyId":"","modality":"Small molecule","firstApprovalDate":"1994","enrichmentLevel":3,"visitCount":0,"regulatoryByCountry":[{"country_code":"CA","regulator":"Health Canada","status":"approved","approval_date":null,"mah":"","brand_name_local":"","application_number":""},{"country_code":"US","regulator":"FDA","status":"approved","approval_date":null,"mah":null,"brand_name_local":null,"application_number":null},{"country_code":"US","regulator":"FDA","status":"approved","approval_date":null,"mah":"SCHERING","brand_name_local":"RENORMAX","application_number":"NDA020240"}],"trialStats":{"total":0,"withResults":0},"validation":{"fieldsValidated":0,"lastValidatedAt":"2026-04-20T01:14:41.169902+00:00","fieldsConflicting":1,"overallConfidence":0.8},"verificationStatus":"partial","dataCompleteness":{"mechanism":false,"indications":true,"safety":false,"trials":true,"score":2}}